Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 15, 2026
ASO Visual Abstract: National Evaluation of the Management of Melanoma Patients with Multiple Positive Sentinel Lymph Nodes.
Journal: Annals of surgical oncology
Published: November 03, 2025
Pharmacokinetic Drug-Drug Interaction Potential of Oral Anticancer Drugs.
Journal: Clinical pharmacology and therapeutics
Published: September 26, 2025
National Evaluation of the Management of Melanoma Patients with Multiple Positive Sentinel Lymph Nodes.
Journal: Annals of surgical oncology
Published: April 28, 2025
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 17, 2024
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2023
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 27, 2022
Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial.
Journal: Kidney cancer journal : official journal of the Kidney Cancer Association
Published: November 12, 2021
Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 12, 2021
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: February 05, 2021
Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 20, 2020
Last Updated: 09/26/2026